Mark E. Hensley - Chief Operating Officer at Heron Therapeutics, Inc. /De/

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Operating Officer
Stock Symbol
HRTX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Mark E. Hensley since 12/1/2024

Holdings reported by Mark E. Hensley for Heron Therapeutics, Inc. /De/

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Employee Performance Stock Option (Right to Buy) 900K $1.98M $2.20 Apr 28, 2025 Direct Common Stock 900K
Employee Stock Option (Right to Buy) 500K $1.1M $2.20 Apr 28, 2025 Direct Common Stock 500K
Restricted Stock Units 500K May 6, 2025 Direct Common Stock

Transactions reported by Mark E. Hensley for Heron Therapeutics, Inc. /De/

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.